VAXCYTE INC. - COMMON STOCK
73.02
13-March-25 15:00:02
15 minutes delayed
Stocks
-0.22
-0.30%
Today's range
71.69 - 76.51
ISIN
N/A
Source
NASDAQ
-
02 Feb 2024 17:39:14 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
01 Feb 2024 15:05:49 By Nasdaq GlobeNewswire
-
Vaxcyte Announces Pricing of $750 Million Public Offering
30 Jan 2024 22:37:41 By Nasdaq GlobeNewswire
-
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
30 Jan 2024 15:01:28 By Nasdaq GlobeNewswire
-
29 Jan 2024 07:30:33 By Nasdaq GlobeNewswire
-
Vaxcyte Appoints Whitney Jones as Chief People Officer
16 Jan 2024 15:01:00 By Nasdaq GlobeNewswire
-
04 Jan 2024 15:01:42 By Nasdaq GlobeNewswire
-
Vaxcyte Appoints Jacks Lee to Board of Directors
28 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
09 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
06 Nov 2023 15:03:00 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at Upcoming Investor Conferences
31 Oct 2023 15:05:00 By Nasdaq GlobeNewswire
-
19 Oct 2023 07:30:00 By Nasdaq GlobeNewswire
-
16 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
19 Sep 2023 15:05:00 By Nasdaq GlobeNewswire
-
Vaxcyte Reports Second Quarter 2023 Financial Results and Provides Business Update
08 Aug 2023 15:03:00 By Nasdaq GlobeNewswire
-
11 Jul 2023 07:30:00 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at the Jefferies Healthcare Conference
01 Jun 2023 15:05:00 By Nasdaq GlobeNewswire
-
Vaxcyte Reports First Quarter 2023 Financial Results and Provides Business Update
08 May 2023 15:03:00 By Nasdaq GlobeNewswire